Literature DB >> 31570769

Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.

Gian Paolo Dagrada1, Silvana Pilotti2, Silvia Brich2, Fabio Bozzi2, Federica Perrone2, Elena Tamborini2, Antonello Domenico Cabras3, Marcello Deraco4, Silvia Stacchiotti5.   

Abstract

The aim of this study was to assess the performance of fluorescence in situ hybridization (FISH) in identifying the copy number profiles of the three key peritoneal mesothelioma tumor suppressor genes BAP1, CDKN2A, and NF2, with particular emphasis on minute homozygous deletions, a copy number abnormality recently unveiled at the 3p21 (BAP1) chromosomal region using high-throughput methods. FISH was performed on 75 formalin-fixed-paraffin-embedded peritoneal mesotheliomas and recognized two types of monoallelic loss (monosomy, and hemizygous deletion) and two types of biallelic loss (canonical homozygous deletion with a complete loss of FISH signal and homozygous deletion with diminished signal). Diminished FISH signals revealed deletions occurring within the genomic region covered by the gene-specific probe and affected all three tumor suppressors. BAP1 homozygous deletions with diminished signal outnumbered canonical homozygous deletions (13 vs 3): conversely, canonical homozygous deletions were prevalent for CDKN2A (2 vs 14). Diminished signal homozygous deletion was the only pattern of biallelic loss observed for NF2 (2 cases). Hemizygous deletion mainly affected BAP1 (21 vs 6), while monosomy was prevalent for CDKN2A (14 vs 7) and particularly for NF2 where it accounts for all monoallelic losses. FISH/immunohistochemistry (BAP1, CDKN2A, and MTAP) correlation showed that all homozygous deletions, including those with diminished signals, resulted in a null BAP1 and CDKN2A immunophenotype but only canonical CDKN2A homozygous deletions resulted in MTAP loss of expression. BAP1 hemizygous deletion, but not monosomy, was also invariably associated with loss of protein expression whereas neither type of CDKN2A monoallelic loss correlated with p16 or MTAP immunohistochemistry. Array comparative genomic hybridization performed on a spontaneously emerging peritoneal mesothelioma cell line provided support for the interpretation of the FISH patterns and allowed us to extend the number of chromatin remodeling factors involved in mesothelioma to SETD7 and PCGF5, two previously unreported genes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31570769     DOI: 10.1038/s41379-019-0371-0

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  3 in total

1.  Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.

Authors:  Yoshie Yoshikawa; Ayuko Sato; Tohru Tsujimura; Tomonori Morinaga; Kazuya Fukuoka; Shusai Yamada; Aki Murakami; Nobuyuki Kondo; Seiji Matsumoto; Yoshitomo Okumura; Fumihiro Tanaka; Seiki Hasegawa; Tomoko Hashimoto-Tamaoki; Takashi Nakano
Journal:  Int J Oncol       Date:  2011-08-12       Impact factor: 5.650

2.  Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

Authors:  Peter B Illei; Valerie W Rusch; Maureen F Zakowski; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

3.  Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.

Authors:  Gamze Ugurluer; Kenneth Chang; Mauricio E Gamez; Andrea L Arnett; Ritujith Jayakrishnan; Robert C Miller; Terence T Sio
Journal:  Anticancer Res       Date:  2016-05       Impact factor: 2.480

  3 in total
  6 in total

1.  Molecular characterization of diffuse malignant peritoneal mesothelioma.

Authors:  Yin P Hung; Fei Dong; Matthew Torre; Christopher P Crum; Raphael Bueno; Lucian R Chirieac
Journal:  Mod Pathol       Date:  2020-06-05       Impact factor: 7.842

2.  Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma.

Authors:  David B Chapel; Jason L Hornick; Julianne Barlow; Raphael Bueno; Lynette M Sholl
Journal:  Mod Pathol       Date:  2022-04-22       Impact factor: 8.209

Review 3.  Molecular testing on serous effusion: An update.

Authors:  Saumya Sahu; Parikshaa Gupta; Pranab Dey
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

Review 4.  Molecular Pathways in Peritoneal Mesothelioma: A Minireview of New Insights.

Authors:  Francesco Fortarezza; Federica Pezzuto; Andrea Marzullo; Domenica Cavone; Daniele Egidio Romano; Antonio d'Amati; Gabriella Serio; Luigi Vimercati
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 5.  The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine.

Authors:  Marina Di Domenico; Andrea Ballini; Mariarosaria Boccellino; Salvatore Scacco; Roberto Lovero; Ioannis Alexandros Charitos; Luigi Santacroce
Journal:  J Pers Med       Date:  2022-03-24

6.  Clinical significance of 9P21 gene combined with BAP1 and MTAP protein expression in diagnosis and prognosis of mesothelioma serous effusion.

Authors:  Guan-Ying Ma; Shuai Shi; Ping Wang; Xing-Guang Wang; Zhi-Gang Zhang
Journal:  Biomed Rep       Date:  2022-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.